Lack of herpes virus DNA in choroidal tissues of a patient with serpiginous choroiditis

Ophthalmology

Volumn 111, Issue 11, 2004, Pages 2071-2075

  Akpek, Esen Karamursel ^a   Chan, Chi Chao ^b   Shen, Defen ^b   Green, W Richard ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; VIRUS DNA;

ADULT; ARTICLE; CARDIOPULMONARY ARREST; CASE REPORT; CHOROID; CHOROID DISEASE; CLINICAL FEATURE; CYTOMEGALOVIRUS; DEATH; DISEASE COURSE; EPSTEIN BARR VIRUS; EYE FUNDUS; EYE INFLAMMATION; GENE AMPLIFICATION; HERPES VIRUS; HUMAN; LASER COAGULATION; LYMPHOCYTIC INFILTRATION; MALE; MEDICAL ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SERPIGINOUS CHORIODITIS; VARICELLA ZOSTER VIRUS;

CHOROID; CHOROIDITIS; DNA, VIRAL; EYE INFECTIONS, VIRAL; GENOME, VIRAL; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 7444250654     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.03.034     Document Type: Article

References (31)

1. Akpek E.K., Ilhan-Sarac O. New treatments for serpiginous choroiditis. Curr Opin Ophthalmol. 14:2003;128-131
2. Jabs DA, Akpek EK. Immunosuppression for posterior uveitis. Retina. In press
3. Hardy R.A., Schatz H. Macular geographic helicoid choroidopathy. Arch Ophthalmol. 105:1987;1237-1242
4. Mansour A.M., Jampol L.M., Packo K.H., Hrisomalos N.F. Macular serpiginous choroiditis. Retina. 8:1988;125-131
5. Sahu D.K., Rawoof A., Sujatha B. Macular serpiginous choroiditis. Indian J Ophthalmol. 50:2002;189-196
6. Wu J.S., Lewis H., Fine S.L., et al. Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina. 9:1989;292-301
7. Gass JDM. Stereoscopic Atlas of the Macular Diseases, Diagnosis and Treatment. 4th ed. Vol. 1. St. Louis: Mosby; 1997:49-286
8. Secchi A.G., Tognon M.S., Maselli C. Cyclosporine-A in the treatment of serpiginous choroiditis. Int Ophthalmol. 14:1990;395-399
9. Hooper P.L., Kaplan H.J. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 98:1991;944-951., discussion 951-2
10. Araujo A.A., Wells A.P., Dick A.D., Forrester J.V. Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome. Br J Ophthalmol. 84:2000;979-982
11. Akpek E.K., Baltatzis S., Yang J., Foster C.S. Long-term immunosuppressive treatment of serpiginous choroiditis. Ocul Immunol Inflamm. 9:2001;153-167
12. Christmas N.J., Oh K.T., Oh D.M., Folk J.C. Long-term follow-up of patients with serpiginous choroiditis. Retina. 22:2002;550-556
13. Akpek E.K., Jabs D.A., Tessler H.H., et al. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 109:2002;1506-1513
14. Priya K., Madhavan H.N., Reiser B.J., et al. Association of herpesviruses in the aqueous humor of patients with serpiginous choroiditis a polymerase chain reaction-based study. Ocul Immunol Inflamm. 10:2002;253-261
15. Johnson G., Nelson S., Petric M., Tellier R. Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J Clin Microbiol. 38:2000;3274-3279
16. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea. 20:2001;1-13
17. Labetoulle M., Maillet S., Efstathiou S., et al. HSV1 latency sites after inoculation in the lip assessment of their localization and connections to the eye. Invest Ophthalmol Vis Sci. 44:2003;217-225
18. Kaye S.B., Lynas C., Patterson A., et al. Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol. 75:1991;195-200
19. Pavan-Langston D., Rong B.L., Dunkel E.C. Extraneuronal herpetic latency animal and human corneal studies. Acta Ophthalmol Suppl. 192:1989;135-141
20. Abghari S.Z., Stulting R.D. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice. Invest Ophthalmol Vis Sci. 29:1988;239-243
21. Shimeld C., Tullo A.B., Hill T.J., et al. Spread of herpes simplex virus and distribution of latent infection after intraocular infection of the mouse. Arch Virol. 85:1985;175-187
22. Rong B.L., Pavan-Langston D., Weng Q.P., et al. Detection of herpes simplex virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification. Invest Ophthalmol Vis Sci. 32:1991;1808-1815
23. Wenkel H., Rummelt V., Fleckenstein B., Naumann G.O. Detection of varicella zoster virus DNA and viral antigen in human eyes after herpes zoster ophthalmicus. Ophthalmology. 105:1998;1323-1330
24. Rummelt V., Wenkel H., Rummelt C., et al. Detection of varicella zoster virus DNA and viral antigen in the late stage of bilateral acute retinal necrosis syndrome. Arch Ophthalmol. 110:1992;1132-1136
25. Gordon Y.J., Rao H., Arullo-Cruz T. Immunosuppression promotes ocular virus replication and CNS neurovirulence following corneal inoculation with an avirulent herpes simplex type 1 thymidine kinase negative mutant. Curr Eye Res. 3:1984;651-657
26. Laatikainen L., Erkkila H. Serpiginous choroiditis. Br J Ophthalmol. 58:1974;777-783
27. Maumenee A.E. Clinical entities in "uveitis:" an approach to the study of intraocular inflammation. Am J Ophthalmol. 69:1970;1-27
28. Gupta V., Gupta A., Arora S., et al. Presumed tubercular serpiginouslike choroiditis clinical presentations and management. Ophthalmology. 110:2003;1744-1749
29. Erkkila H., Laatikainen L., Jokinen E. Immunological studies on serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 219:1982;131-134
30. Bouchenaki N., Cimino L., Auer C., et al. Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monatsbl Augenheilkd. 219:2002;243-249
31. Herbort C.P., LeHoang P., Guex-Crosier Y. Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol. Ophthalmology. 105:1998;432-440